Cowen Maintains Buy on Royalty Pharma plc (RPRX) Feb 27, 2026
Cowen keeps RPRX analyst rating at Buy and raises PT to $50 on Feb 27, 2026
-
-
AGSTRA.BO AGS Transact BSE pre-market INR 3.67: Earnings 28 Feb 2026 may reset outlook
Pre-market earnings spotlight for AGSTRA.BO stock at INR 3.67 on 28 Feb 2026. Key targets, grade and forecast
-
XRP USD Faces Headwinds at $1.40—Will Ripple’s $4B Bank Push Reverse the Decline?
XRP USD trades at $1.40 amid -3.49% daily loss. Ripple’s $4B deployment targets banks. Technical analysis and price forecast inside.
-
Telecom Italia (TIT.BR) EURONEXT most active 27 Feb 2026: 553M shares draw focus
TIT.BR stock update: price €0.31, volume 553,037,536; Meyka AI forecast and grade included
-
BUCN.SW Bucher Industries (SIX) CHF 379.00 Feb 2026: earnings may reset targets
BUCN.SW stock snapshot: CHF 379.00 at close, earnings due 03 Mar 2026; Meyka AI forecast and grade included
-
Supreme Court of Canada Triggers Terrebonne Rematch – February 27
Supreme Court of Canada voids Terrebonne’s 2025 result, forcing a byelection that could shape a Mark Carney majority and decisions on Quebec–Toronto high-speed rail. Investor takeaways inside.
-
153A.T Caulis, Inc. (JPX) pre-market 28 Feb 2026: top gainer model upside
Pre-market note on 153A.T stock: Caulis, Inc. at JPY 1,085.00 with Meyka AI forecasts and sector context
-
32.00% pre-market drop on HKSE: 0756.HK stock top loser, liquidity alert
0756.HK stock down 32.00% pre-market to HKD 0.51 on HKSE; Meyka AI grade, forecast and key risks
-
31M.SG Mobility One Ltd. (STU) +27.71% 27 Feb 2026: top gainer with analyst insight
31M.SG stock jumps 27.71% on 27 Feb 2026; quick technical, grade and price forecast for traders
-
Hong Kong Budget Surplus for 2025-26 as IPOs Revive — February 28
Hong Kong budget surplus returns for 2025-26 as IPOs revive and stock market turnover improves, lifting stamp duty revenue. See drivers, market impact, and what investors should watch next.
